Ocugen (OCGN) Interest Coverage Ratio (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.92% |
| Dec 31, 2025 | 4.88% |
| Mar 31, 2025 | 49.90% |
| Dec 31, 2024 | 94.96% |
| Dec 31, 2021 | -28.31% |
| Sep 30, 2021 | 55.65% |
| Jun 30, 2021 | -262.90% |
| Mar 31, 2021 | -1,438.16% |
| Dec 31, 2020 | 34.21% |
| Sep 30, 2020 | -156.91% |
| Jun 30, 2020 | 94.82% |
| Mar 31, 2020 | 9.25% |
| Dec 31, 2019 | -8,367.07% |
| Sep 30, 2019 | 61.71% |
| Jun 30, 2019 | -27.89% |
| Mar 31, 2019 | 12.49% |
| Dec 31, 2018 | -231.32% |
| Dec 31, 2016 | -375.69% |
| Sep 30, 2016 | 28.97% |
| Jun 30, 2016 | -14.01% |
| Mar 31, 2016 | -8.60% |
| Dec 31, 2015 | -8.12% |
| Sep 30, 2015 | -19.68% |
| Jun 30, 2015 | -129.98% |
| Mar 31, 2015 | -156.34% |
| Dec 31, 2014 | 93.70% |